SHANGHAI — China’s humanoid robot boom has moved from technology showcases to the stock market — and investors are showing just how much they are willing to pay for a piece of it.
Unitree Robotics, one of China’s best-known makers of humanoid robots and robotic dogs, was set for an extraordinary debut on Shanghai’s STAR Market on Wednesday, August 19, with pre-open indications pointing to its shares opening more than 600% above their IPO price.
The dramatic move puts a spotlight not only on Unitree, but also on the increasingly intense investor enthusiasm surrounding artificial intelligence, robotics and so-called embodied AI in China.
And the scale of the excitement had been building well before the first day of trading.
From 150.80 Yuan to a Potential Blockbuster Debut
Unitree priced its initial public offering at 150.80 yuan per share, valuing the Hangzhou-based robotics company at roughly 61 billion yuan, or about US$9 billion, before its trading debut.
The company sold roughly 40.4 million shares and raised about 6.1 billion yuan, or roughly US$900 million, through the offering.
That alone would have made the IPO one of the most closely watched Chinese technology listings of the year.
But investor demand turned the offering into something much bigger.
Reuters reported that the IPO was more than 8,000 times oversubscribed by retail investors at one stage of the allocation process. The extraordinary demand meant the chances of an individual investor receiving shares were extremely small.
Other exchange figures showed the final retail portion was 5,526 times subscribed, with about 9.8 million orders submitted by individual investors.
The differing figures reflect different stages and calculations in the IPO allocation process rather than contradictory accounts.
Why Investors Are Betting So Aggressively on Unitree
Unitree is not merely selling a futuristic idea.
The company has already developed one of the most recognizable robotics product portfolios coming out of China, including its G1 and H1 humanoids and its four-legged robotic platforms.
More importantly for investors, Unitree has demonstrated rapidly expanding sales.
According to figures highlighted by the Shanghai Stock Exchange, Unitree’s revenue climbed from approximately 159 million yuan in 2023 to 393 million yuan in 2024 and 1.70 billion yuan in 2025.
That means revenue increased more than tenfold in just two years.
International customers are also significant to the business. Overseas sales generated roughly 732 million yuan in 2025, accounting for about 43.7% of main-business revenue, according to the exchange.
Those numbers help explain why investors are treating Unitree differently from many early-stage robotics companies that remain almost entirely dependent on research funding and demonstrations.
Then Unitree Unveiled ‘Superman’
The company added even more fuel to the excitement immediately before its listing.
Unitree unveiled a new humanoid robot nicknamed “Superman” as its Shanghai debut approached, extending the company’s reputation for producing machines capable of unusually athletic movements.
The timing was difficult to ignore.
Unitree’s market debut also coincides with heightened attention on China’s robotics industry surrounding major robotics events in Beijing, where companies are trying to prove that humanoid machines can move beyond viral demonstrations and become commercially useful products.
That distinction could determine whether today’s enormous robotics valuations ultimately prove justified.
China Wants Robots Out of the Laboratory
Unitree’s IPO represents something larger than one company’s stock-market debut.
China has made robotics, artificial intelligence and advanced manufacturing increasingly important parts of its technology strategy, as companies race to build machines capable of working in factories, warehouses, hospitality environments and eventually homes.
The next stage of the competition is increasingly focused on embodied intelligence — combining AI systems with machines capable of physically interacting with the world.
That has attracted hundreds of companies into China’s robotics ecosystem.
But the commercial challenge remains substantial.
Reuters reported this week that despite eye-catching demonstrations involving running, jumping and other complex movements, China’s humanoid robotics sector still needs to demonstrate that these machines can perform economically useful tasks with limited human supervision.
In other words, making a robot perform a backflip is impressive.
Making one reliably perform an eight-hour factory shift — at a cost that makes financial sense — is considerably harder.
Unitree Is Already Profitable — But the Race Is Getting Expensive
Unitree has another advantage that helps explain the enthusiasm surrounding its listing: unlike many emerging robotics companies, it has already demonstrated profitability.
The Shanghai Stock Exchange said Unitree recorded 278.21 million yuan in net profit in 2025, alongside its rapid revenue expansion.
At the same time, developing increasingly capable humanoids requires enormous spending on artificial intelligence, motors, sensors, batteries, computing systems and manufacturing.
That means investors are effectively betting that Unitree can turn its technological lead and manufacturing capabilities into a much larger commercial robotics business.
Tesla, Boston Dynamics and a Global Robot Race
Unitree’s ambitions also extend far beyond China.
Its emergence places the company in an increasingly global contest involving American, European, Japanese, South Korean and Chinese robotics developers.
Reuters has described Unitree as competing in a field that includes Tesla and Boston Dynamics, while China’s manufacturing ecosystem could give domestic robotics companies an important advantage in reducing production costs and scaling hardware quickly.
That manufacturing advantage may become critical.
Humanoid robots will probably need to become dramatically cheaper before they can be deployed at the enormous scale envisioned by their developers.
Unitree has deliberately positioned some of its products at lower price points than many competing research-oriented humanoids, potentially widening access to universities, developers and companies experimenting with embodied AI.
But a 600% Debut Raises Another Question
The extraordinary market reaction also creates a risk.
Investors are no longer valuing Unitree solely on the robots it sells today.
They are effectively pricing in expectations that humanoid robots could become an enormous new technology platform — potentially comparable in importance to smartphones, electric vehicles or artificial intelligence infrastructure.
Chinese technology valuations have already risen sharply amid intense enthusiasm surrounding AI and strategically important domestic technologies. That has also prompted questions about whether expectations are running ahead of near-term commercial fundamentals.
Unitree could therefore become an important test.
If its robots move rapidly from demonstrations and research laboratories into factories and other real-world workplaces, today’s extraordinary valuation may eventually look less extreme.
If commercialization takes longer than investors expect, the same enthusiasm could become difficult to sustain.
The Bigger Story Behind Unitree’s IPO
For years, humanoid robots were mostly treated as spectacular engineering experiments — machines that could walk, dance, run or perform carefully rehearsed demonstrations.
That era may be ending.
The question increasingly facing companies such as Unitree is no longer simply:
Can you build a humanoid robot?
It is:
Can you manufacture thousands of them, make them useful, sell them profitably and convince businesses that replacing or supplementing human labor makes economic sense?
Unitree’s explosive Shanghai debut suggests investors have already placed an enormous bet on the answer.
Now the robots have to prove them right.
Leave a Reply